Polyarthralgia and/or polyarthritis were the first symptoms to appear in the majority of ACPA-positive ASS patients (n = 88%), whereas myositis and/or ILD were present at onset in 41% and 35% of patients, respectively. This evidence concerns the gene PRTN3 and interstitial lung disease.